跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Omari - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Omari
Approved
STANDARD
Omari
Khandelwal Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
829f83699883bf16
Company
Khandelwal Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
829f83699883bf16
Drug Approval Philippines Name
Omari
Product Name
Omari
Registration Number
DRP-4660-02
Brand Name
Omari
Generic Name
Methotrexate
Dosage Form
Solution for Injection (I.M./I.V./Intrathecal)
Dosage Strength
25 mg/mL (50 mg/2 mL)
Manufacturer
Khandelwal Laboratories Pvt. Ltd.
Importer
Medethix, Inc.
Distributor
Kaufmann Pharma Inc.
Issuance Date
27 September 2024
Expiry Date
06 September 2028
Pharmacologic Category
Antineoplastic (Cell Cycle-Specific Agent)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
829f83699883bf16
Type
Standard
Back to Philippines FDA Approvals